The 2016 Guideline for Prescribing Opioids for Chronic Pain, produced by the Centers for Disease Control and Prevention (CDC), effectively changed opioid prescribing with a decrease in the number of high-dose opioid prescriptions. Since then, however, there has been misapplication of the recommendations and increasing disparities or inequitable access to effective pain management, which necessitated the 2022 update to the CDC Opioid Prescribing Guideline. In order to incorporate the strategies suggested in the new Guideline for creating safe and effective pain management treatments for patients, providers need to understand the differences between acute, subacute, and chronic pain pathways and the biopsychosocial factors that impact pain manifestations and affect treatment options.
In this recorded CME Outfitters webcast entitled, Finding Balance: Optimizing the Treatment of Patients with Pain, a panel of expert faculty will discuss the 2022 CDC Guideline for Prescribing Opioids for Chronic Pain, changes made since the last Guideline published in 2016, and ways to utilize the new Guideline in the management of pain. Emphasis will be on the need to individualize treatment to the needs of the patient, use of multi-modal pain management strategies, understanding the different pain pathways and biopsychosocial factors individual patients face trying to manage pain.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please click here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Physicians, dentists, physician associates (PAs), nurse practitioners (NPs), nurses, psychologists, and optometrists
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Goree reports the following financial relationships:
Consultant: Abbott; Saluda Medical; and Stratus Medical, LLC
Research Support: Mainstay Medical (to UAMS) and SPR Therapeutics (to UAMS)
Dr. Durham reports no financial relationships to disclose.
Dr. Hyde reports no financial relationships to disclose.
Disclosures were obtained from the following peer reviewer and CME Outfitters, LLC, staff, with no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).